SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes

BACKGROUND: No study evaluated the incidence of intra-stent restenosis (ISR)-related events in patients with type 2 diabetes (T2DM) and acute myocardial infarction (AMI) treated or not with sodium/glucose cotransporter 2 inhibitors (SGLT2i). METHODS: We recruited 377 patients with T2DM and AMI under...

Descripción completa

Detalles Bibliográficos
Autores principales: Marfella, Raffaele, Sardu, Celestino, D’Onofrio, Nunzia, Fumagalli, Carlo, Scisciola, Lucia, Sasso, Ferdinando Carlo, Siniscalchi, Mario, Marfella, Ludovica Vittoria, D’Andrea, Davide, Minicucci, Fabio, Signoriello, Giuseppe, Cesaro, Arturo, Trotta, Maria Consiglia, Frigé, Chiara, Prattichizzo, Francesco, Balestrieri, Maria Luisa, Ceriello, Antonio, Calabrò, Paolo, Mauro, Ciro, del Viscovo, Luca, Paolisso, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960194/
https://www.ncbi.nlm.nih.gov/pubmed/36829203
http://dx.doi.org/10.1186/s12916-023-02781-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960194/
https://www.ncbi.nlm.nih.gov/pubmed/36829203
http://dx.doi.org/10.1186/s12916-023-02781-2

Ejemplares similares